Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM.

Mayo Clin Proc. 2007 Jan;82(1):29-39. Review.

PMID:
17285783
2.

Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, Caples SM, Erwin PJ, Montori VM.

Mayo Clin Proc. 2007 Jan;82(1):20-8. Review.

PMID:
17285782
3.

Testosterone for peri- and postmenopausal women.

Somboonporn W, Davis S, Seif MW, Bell R.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004509. Review.

PMID:
16235365
4.

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.

Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A.

Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. Review.

PMID:
16117815
5.

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

Xu L, Freeman G, Cowling BJ, Schooling CM.

BMC Med. 2013 Apr 18;11:108. doi: 10.1186/1741-7015-11-108.

6.

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S.

J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1451-7.

PMID:
16339333
7.

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.

Tracz MJ, Sideras K, Boloña ER, Haddad RM, Kennedy CC, Uraga MV, Caples SM, Erwin PJ, Montori VM.

J Clin Endocrinol Metab. 2006 Jun;91(6):2011-6. Epub 2006 May 23. Review.

PMID:
16720668
8.

Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.

Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75. doi: 10.1210/jc.2009-2575. Review.

PMID:
20525906
9.

The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials.

Feringa HH, Laskey DA, Dickson JE, Coleman CI.

J Am Diet Assoc. 2011 Aug;111(8):1173-81. doi: 10.1016/j.jada.2011.05.015. Review.

PMID:
21802563
10.

Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials.

Casanova G, Bossardi Ramos R, Ziegelmann P, Spritzer PM.

J Clin Endocrinol Metab. 2015 Mar;100(3):1028-37. doi: 10.1210/jc.2014-3301. Epub 2014 Dec 16. Review.

PMID:
25514104
11.

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

Huang ES, Meigs JB, Singer DE.

Am J Med. 2001 Dec 1;111(8):633-42.

PMID:
11755507
12.

Effects of testosterone on sexual function in men: results of a meta-analysis.

Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A.

Clin Endocrinol (Oxf). 2005 Oct;63(4):381-94. Review.

PMID:
16181230
13.

Testosterone and cardiovascular disease.

Schooling CM.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):202-8. doi: 10.1097/MED.0000000000000065. Review.

PMID:
24722171
14.

Testosterone treatment in the aging male: myth or reality?

Nigro N, Christ-Crain M.

Swiss Med Wkly. 2012 Mar 19;142:w13539. doi: 10.4414/smw.2012.13539. Review.

15.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

16.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
17.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
18.

Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2011;11(1):1-93. Epub 2011 Feb 1.

19.

Physical therapy for Bell's palsy (idiopathic facial paralysis).

Teixeira LJ, Valbuza JS, Prado GF.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006283. doi: 10.1002/14651858.CD006283.pub3. Review.

PMID:
22161401
20.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415

Supplemental Content

Support Center